Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
134 people get EXAM articles and Market Currents by email alert.
Get email alerts on EXAM »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
-
Insiders Love These 18 High Growth StocksKapitall • Wed, Jan 18, 2012
-
22 CEO Buys of at Least $100,000 in the Past WeekThe Keating Letter • Mon, Aug 15, 2011
-
Marketwire (Feb 27, 2013)
-
Marketwire (Nov 5, 2012)
-
Marketwire (Aug 31, 2012)
-
Marketwire (Aug 2, 2012)
-
Marketwire (May 9, 2012)
-
at MarketWatch.com (Aug 2, 2011)
-
at MarketWatch.com (Jul 26, 2011)
-
at MarketWatch.com (Jul 19, 2011)
-
at MarketWatch.com (Jul 14, 2011)
-
at MarketWatch.com (Jul 12, 2011)
-
at MarketWatch.com (Jun 30, 2011)
-
at MarketWatch.com (Jun 23, 2011)
EXAM vs. ETF Alternatives
Company Description
Currently, there's no company description for EXAM.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, June 4, 1:22 PM ExamWorks (EXAM +2.7%) moves up on reports that CEO James Price bought 11K shares in the company at $18.92 a share on June 3. Comment! [Healthcare]
-
Wednesday, May 8, 5:53 PM
After-hours top gainers, as of 5:30 p.m.: TSLA +17%. GMCR +12%. GRPN +10%. EOX +6%. EXAM +6%.
After-hours top losers: RAX -17%. OME -14%. LPSN -13%. MNST -12%. OFIX -9%. Comment! [On the Move] - Wednesday, May 8, 5:02 PM ExamWorks (EXAM): Q1 EPS of -$0.13 misses by $0.06. Revenue of $148.7M beats by $3.13M. (PR) Comment! [Earnings, Breaking News]
- Monday, April 8, 11:23 AM ExamWorks (EXAM +7.1%) gets a lift from a price target hike at Credit Suisse. The bank rates the IME provider's stock outperform and today raised its target from $18 to $21. Comment! [Healthcare, On the Move]
- Wednesday, February 27, 4:50 PM ExamWorks (EXAM): Q4 EPS of -$0.08 beats by $0.08. Revenue of $139.6M (+21.1% Y/Y) beats by $3.83M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Monday, November 5, 2012, 6:07 PM ExamWorks (EXAM): Q3 EPS of -$0.14 beats by $0.03. Revenue of $130.1M (+19.1% Y/Y) beats by $2M. (PR) Comment! [Earnings, Healthcare]
- Friday, August 31, 2012, 2:53 PM ExamWorks Group (EXAM -1.4%) completes its acquisition of MedHealth Holdings for A$93M in cash, giving it entrance into the independent medical examination services market in Australia. The company expects the deal to be immediately accretive to earnings. Comment! [Healthcare, M&A]
- Thursday, August 2, 2012, 5:44 PM Examworks Group (EXAM): Q2 EPS of -$0.10 beats by $0.01. Revenue of $127.8M (+19.8% Y/Y) beats by $3M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, February 28, 2012, 6:20 PM Examworks Group (EXAM): Q4 EPS of -$0.15 misses by $0.05. Revenue of $115.3M (+112% Y/Y). (PR) Comment! [Earnings, Healthcare]
- Friday, November 4, 2011, 10:03 AM ExamWorks (EXAM -23.1%) falls off sharply after steering FY11 revenue guidance below the estimates of analysts. The medical examination firm now sees revenue falling in at $390M-$395M - inclusive of results from its acquisitions, well-below prior guidance of $405M-$415M. Comment! [On the Move]
- Wednesday, August 3, 2011, 3:56 PM ExamWorks (EXAM) is off -34%, despite topping Q2 revenue estimates and reporting an in-line EPS number. Investors appear concerned over the rising costs associated with maintaining growth margins, as the company's cost of revenues soared 219% Y/Y and SGA expenses jumped 158%. Comment! [Healthcare, Earnings, On the Move]
LATEST REPLIES
